In this article, we will take a detailed look at 12 Stocks That Are About to Explode.

Despite the current headwinds and uncertainty (which also caused heightened volatility in the last 2 weeks), there are indications that the recent US stock market correction was short-lived, and the market could return to growth. Helping the stock market move higher was a rebound in February’s retail sales, following a downward revision in January. The pattern of evolution hints that January’s sluggishness was more weather-driven and had little to do with the general strength of the consumer. Yardeni Research recently expressed a strong belief that retail sales will move higher in March and April, supporting the economy. Also, the recent cuts in real GDP growth projections for the first quarter of 2025 by the Atlanta Fed are primarily driven by a minority of economic niches dependent on public spending, while the core economic sectors remain strong. With that being said, we are currently at a potential bottom of the market correction, which could represent a favorable moment to pick stocks that are about to explode.

Insider trading, specifically purchases made by key executive officers and directors, can often signal future stock price appreciation. When insiders buy shares of their own company, it suggests that those with the most intimate knowledge of the firm’s prospects view the stock as undervalued. Economic research supports this idea; for instance, Lakonishok and Lee (2001) found that insider buying tends to precede periods of higher-than-average returns, indicating that insider purchases provide meaningful predictive power regarding stock performance. Therefore, tracking insider transactions, particularly when top management is actively buying shares in companies that are at or near 52-week lows, may help investors anticipate stocks that are about to explode.

READ ALSO: 10 Stocks Set to Explode in 2025

Insider trading signals become particularly relevant as the new Trump 2.0 regime has caused a plethora of industries to crash and trade near their lows – the tariff news cycle has become exhausting, causing uncertain capital spending plans on top of direct cuts to many government programs and spending. The policies of the new US administration could indeed have long-lasting effects on many industries, such as government contracting (the closure of USAID represents a giant erosion of the total addressable market). Here’s what Treasury Secretary Scott Bessent recently said:

“The market and the economy have become hooked, become addicted, to excessive government spending, and there’s going to be a detox period… Could we be seeing this economy that we inherited starting to roll a bit? Sure. Look, there’s going to be a natural adjustment as we move away from public spending.”

Despite major changes being made in some directions, we do not exclude the possibility that many companies, that reached new lows since the election day of November 2024, are mainly driven by investors’ fears and uncertainty, which may or may not materialize. For instance, many healthcare stocks have been trading lower on fears that Republicans will start digging into Medicare/Medicaid reimbursement policies and potentially interfere with the revenue base of companies relying on those programs. In this context, watching for potential hidden signals from insiders (such as significant insider buying) may help clear out any uncertainty, fear, and doubts by providing a tangible indication of management’s confidence in the company’s future prospects. Given this, we will take a look at stocks that are about to explode.

Our Methodology

For this article, we used Insider Monkey’s insider trading screener to find stocks with at least two insiders buying shares worth at least $100,000 in 2025. Then, we considered only the stocks that are at or near their 52-week low. Our belief is that at least two insiders buying a significant amount of stock while the share price is at or near the lows represents an increased probability that the bottom is in rear-view mirror. Finally, we compare the list with our proprietary Q4 2024 database of hedge funds’ ownership and include in the article the top 12 stocks with the largest number of hedge funds that own the stock. Analysts’ projections for each stock’s upside potential were also included to assess their likelihood of significant growth.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

12. Arcosa, Inc. (NYSE:ACA)

Number of Hedge Fund Holders: 23

Analysts’ Upside Potential as of March 27: 34.33%

Arcosa, Inc. (NYSE:ACA) provides infrastructure-related products and solutions across construction, engineered structures, and transportation markets primarily in North America. The company’s operations include the manufacturing of construction aggregates, specialty materials, steel structures such as transmission towers and wind towers, storage tanks, and barge and rail transportation equipment. ACA serves diverse sectors, including energy, transportation, industrial, and construction, supplying materials and engineered products essential for infrastructure development and improvement.

2024 was a transformative year for Arcosa, Inc. (NYSE:ACA), marked by successful portfolio optimization through expanding growth businesses while reducing complexity and cyclicality. The company delivered double-digit organic growth, demonstrating the strength of its infrastructure-led portfolio. Significant margin expansion was achieved through higher-margin acquisitions and organic improvements, supported by noncore asset divestitures. The company generated robust free cash flow, positioning itself for debt reduction in 2025 and continued growth beyond. Strategic acquisitions, including Stavola and Ameron, contributed positively to margin expansion.

Arcosa, Inc. (NYSE:ACA) successfully completed several organic initiatives, including a new concrete pole plant in Florida and a wind tower facility in New Mexico. Construction Products now accounts for approximately 62% of adjusted EBITDA, nearly double its contribution from 2018. For 2025, management anticipates revenues between $2.8 billion to $3 billion and adjusted EBITDA ranging from $545 million to $595 million, implying 30% growth at the midpoint. The guidance incorporates double-digit organic and inorganic growth, with a slightly higher weight toward inorganic growth due to nine additional months of Stavola in 2025. With at least 2 insiders buying more than $100,000 worth of stock in 2025, ACA is one of the stocks that are about to explode.

11. Ashland Inc. (NYSE:ASH)

Number of Hedge Fund Holders: 24

Analysts’ Upside Potential as of March 27: 3.7%

Ashland Inc. (NYSE:ASH) is a global specialty chemicals company providing ingredients and performance-enhancing solutions primarily for consumer and industrial markets. The company operates through segments such as personal care, pharmaceuticals, coatings, adhesives, nutraceuticals, and specialty additives, producing cellulose ethers, biofunctional ingredients, rheology modifiers, and other specialized formulations. ASH serves diverse end-markets, including personal care products, pharmaceuticals, food and beverages, paints and coatings, construction materials, and industrial manufacturing.

Ashland Inc. (NYSE:ASH)’s Q1 2025 sales were $405 million, down 14% YoY, with the decline primarily driven by portfolio optimization actions, including the nutraceutical divestiture. The company proactively moved several plant maintenance turnarounds into the first quarter to enable greater operational flexibility, which impacted Q1 absorption and resulted in approximately $5 million in unanticipated EBITDA costs. Despite these challenges, adjusted EBITDA margins remained consistent YoY, with margins expected to improve significantly throughout the year as plans are well positioned and cost savings are being realized. The company is making progress on its $90 million cost-saving target, with $21 million of opportunities identified and a $12 million annual run rate already achieved from the $30 million restructuring program.

Ashland Inc. (NYSE:ASH) recently announced an agreement to sell its Avoca business, marking a significant step in finalizing its strategic transformation. While facing some softness in European demand and inventory control actions from pharma customers, the company maintained its full-year fiscal 2025 outlook, expecting sales in the range of $1.9 billion to $2.05 billion and adjusted EBITDA in the range of $430 million to $470 million. The company’s strategy focuses on executing in a difficult, uncertain market while positioning for future growth through globalization and innovation initiatives, each aiming to generate $100 million in additional revenue by fiscal year 2027.